Contact
searchSearch
HMP Global

Antibiotics Topic Center

Featured Article

Direct-Acting Oral Anticoagulant Combinations
04/10/2024
04/10/2024
Pharmacy Learning Network
News
Antibiotic Recalled
01/19/2023
Jolynn Tumolo
A prescription antibiotic used to treat tuberculosis is being recalled for failing to meet impurity/degradation specifications.
A prescription antibiotic used to treat tuberculosis is being recalled for failing to meet impurity/degradation specifications.
A prescription antibiotic used...
01/19/2023
Pharmacy Learning Network
News
Legislation to Fund Antibiotic Development for Superbugs Stirs Controversy
12/21/2022
Arthur Allen; Liz Szabo
The PASTEUR Act, which would provide $6 billion to pharmaceutical manufacturers to incentivize antibiotic development, has sparked support and criticism throughout the health care industry.
The PASTEUR Act, which would provide $6 billion to pharmaceutical manufacturers to incentivize antibiotic development, has sparked support and criticism throughout the health care industry.
The PASTEUR Act, which would...
12/21/2022
Pharmacy Learning Network
News
Assessing Antibiotic Exposure Among Patients Admitted to VA Skilled Nursing Facility
12/08/2022
Edan Stanley
“The implementation of an antimicrobial stewardship monitoring program within the long-term care setting could assist in maximizing therapy while reducing antibiotic exposure,” found researchers.
“The implementation of an antimicrobial stewardship monitoring program within the long-term care setting could assist in maximizing therapy while reducing antibiotic exposure,” found researchers.
“The implementation of an...
12/08/2022
Veterans Health Today
From Veterans Health Today
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Fighting Endocarditis One Antibiotic at a Time
09/22/2022
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings reviews guideline recommendations and new research into the use of antibiotics in patients who are about to undergo invasive dental procedures.
Dr Jennings reviews guideline recommendations and new research into the use of antibiotics in patients who are about to undergo invasive dental procedures.
Dr Jennings reviews guideline...
09/22/2022
Pharmacy Learning Network
News
Antibiotic Recalled Over Impurity Findings
02/26/2021
Ascend Laboratories is recalling nine lots of cephalexin for oral suspension because impurity results during testing were “at [the] higher side of the specification limit.”
Ascend Laboratories is recalling nine lots of cephalexin for oral suspension because impurity results during testing were “at [the] higher side of the specification limit.”
Ascend Laboratories is recalling...
02/26/2021
Pharmacy Learning Network
News
Children’s Hospitals Are Partly to Blame as Superbugs Increasingly Attack Kids
01/04/2021
A growing body of research shows that overuse and misuse of antibiotics in children’s hospitals is helping fuel superbugs, which typically strike frail older adults but are increasingly infecting kids—and the pandemic is making things worse.
A growing body of research shows that overuse and misuse of antibiotics in children’s hospitals is helping fuel superbugs, which typically strike frail older adults but are increasingly infecting kids—and the pandemic is making things worse.
A growing body of research shows...
01/04/2021
Pharmacy Learning Network
News
Antibiotic Tablets Recalled
06/03/2020
A Class II recall is active for a prescription antibiotic used to treat bacterial infections.
A Class II recall is active for a prescription antibiotic used to treat bacterial infections.
A Class II recall is active for...
06/03/2020
Pharmacy Learning Network
News
Antibiotic Recalled
03/27/2020
A prescription antibiotic used to treat a variety of bacterial infections, such as acne, urinary tract infections, and respiratory infections is being recalled.
A prescription antibiotic used to treat a variety of bacterial infections, such as acne, urinary tract infections, and respiratory infections is being recalled.
A prescription antibiotic used...
03/27/2020
Pharmacy Learning Network
News
Risk of Major Malformations Increased Among Pregnant Women Prescribed Macrolide Antibiotics
02/21/2020
During the first trimester of pregnancy, researchers found macrolide antibiotics increase the risk of major malformations, specifically cardiovascular malformations, compared with those who received penicillin antibiotics.
During the first trimester of pregnancy, researchers found macrolide antibiotics increase the risk of major malformations, specifically cardiovascular malformations, compared with those who received penicillin antibiotics.
During the first trimester of...
02/21/2020
Pharmacy Learning Network
News
Antibiotics Likely Unneeded for Aspiration of Pancreatic Cysts
02/03/2020
Although guidelines recommend antibiotic prophylaxis before or during endoscopic ultrasound-guided fine needle aspiration of pancreatic cysts, the risk of infection from the procedure is low, a randomized controlled trial reveals.
Although guidelines recommend antibiotic prophylaxis before or during endoscopic ultrasound-guided fine needle aspiration of pancreatic cysts, the risk of infection from the procedure is low, a randomized controlled trial reveals.
Although guidelines recommend...
02/03/2020
Pharmacy Learning Network

Newsfeed

News
Antibiotic Recalled
01/19/2023
Jolynn Tumolo
A prescription antibiotic used to treat tuberculosis is being recalled for failing to meet impurity/degradation specifications.
A prescription antibiotic used to treat tuberculosis is being recalled for failing to meet impurity/degradation specifications.
A prescription antibiotic used...
01/19/2023
Pharmacy Learning Network
News
Legislation to Fund Antibiotic Development for Superbugs Stirs Controversy
12/21/2022
Arthur Allen; Liz Szabo
The PASTEUR Act, which would provide $6 billion to pharmaceutical manufacturers to incentivize antibiotic development, has sparked support and criticism throughout the health care industry.
The PASTEUR Act, which would provide $6 billion to pharmaceutical manufacturers to incentivize antibiotic development, has sparked support and criticism throughout the health care industry.
The PASTEUR Act, which would...
12/21/2022
Pharmacy Learning Network
News
Assessing Antibiotic Exposure Among Patients Admitted to VA Skilled Nursing Facility
12/08/2022
Edan Stanley
“The implementation of an antimicrobial stewardship monitoring program within the long-term care setting could assist in maximizing therapy while reducing antibiotic exposure,” found researchers.
“The implementation of an antimicrobial stewardship monitoring program within the long-term care setting could assist in maximizing therapy while reducing antibiotic exposure,” found researchers.
“The implementation of an...
12/08/2022
Veterans Health Today
News
Antibiotics Overprescribed for COPD
10/22/2019
"A recent multicenter trial showed that antibiotic prescribing can be reduced safely in COPD patients by using a rapid diagnostic (C-reactive protein) test," study coauthor Laura Shallcross, PhD, University College London, explained.
"A recent multicenter trial showed that antibiotic prescribing can be reduced safely in COPD patients by using a rapid diagnostic (C-reactive protein) test," study coauthor Laura Shallcross, PhD, University College London, explained.
"A recent multicenter trial...
10/22/2019
Pharmacy Learning Network
News
Each Added Day of Postop Antibiotics Ups Risk of Kidney Injury, C. Diff Infection
05/01/2019
According to new study findings, each additional day of surgical antimicrobial prophylaxis increases the risks of acute kidney injury and Clostridium difficile infection and does not lead to reductions in surgical site infections.
According to new study findings, each additional day of surgical antimicrobial prophylaxis increases the risks of acute kidney injury and Clostridium difficile infection and does not lead to reductions in surgical site infections.
According to new study findings,...
05/01/2019
Pharmacy Learning Network
News
Antibiotic Prescriptions Often Exceed Recommended Treatment Durations
03/07/2019
Many antibiotic prescriptions for common infections in primary care exceed durations recommended by guidelines, according to a new study.
Many antibiotic prescriptions for common infections in primary care exceed durations recommended by guidelines, according to a new study.
Many antibiotic prescriptions...
03/07/2019
Pharmacy Learning Network
News
How Oral Antibiotics Impact Kidney Stone Risk
05/11/2018
A new study examined the risk of kidney stones in patients taking oral antibiotics. 
A new study examined the risk of kidney stones in patients taking oral antibiotics. 
A new study examined the risk...
05/11/2018
Pharmacy Learning Network
News
CDC Reports Rare, Antibiotic Resistant Bacteria in 27 States
04/05/2018
The CDC identified over 200 cases of bacteria with rare antibiotic resistance genes in 27 states during the first 9 months of 2017, according to a new report.
The CDC identified over 200 cases of bacteria with rare antibiotic resistance genes in 27 states during the first 9 months of 2017, according to a new report.
The CDC identified over...
04/05/2018
Pharmacy Learning Network
News
RSV Vaccination Averts Thousands of Severe Outcomes in First Year of US Adult Use
09/26/2025
Hannah Musick
Respiratory syncytial virus (RSV) vaccination among US adults aged 60 and older during the 2023 to 2024 season prevented an estimated 1930 deaths, 23 630 hospitalizations, and 18 326 emergency department visits—benefits that could triple with...
Respiratory syncytial virus (RSV) vaccination among US adults aged 60 and older during the 2023 to 2024 season prevented an estimated 1930 deaths, 23 630 hospitalizations, and 18 326 emergency department visits—benefits that could triple with...
Respiratory syncytial virus...
09/26/2025
Pharmacy Learning Network
News
FDA Announces Class II Recall of Bevacizumab Injection
09/24/2025
Juliet Gallagher
The US Food and Drug Administration (FDA) has announced a nationwide Class II recall of bevacizumab (Avastin) Injection, 1.25mg/0.05mL, packaged in sterile single-dose syringes by Fagron Sterile Services, based in Wichita, Kansas.
The US Food and Drug Administration (FDA) has announced a nationwide Class II recall of bevacizumab (Avastin) Injection, 1.25mg/0.05mL, packaged in sterile single-dose syringes by Fagron Sterile Services, based in Wichita, Kansas.
The US Food and Drug...
09/24/2025
Pharmacy Learning Network
News
Ascend Laboratories Recalls Aripiprazole Lot Nationwide Due to Superpotent Tablets
09/24/2025
Juliet Gallagher
The US Food and Drug Administration (FDA) has announced a Class II recall involving aripiprazole tablets, USP, 10 mg in 30-count bottles.
The US Food and Drug Administration (FDA) has announced a Class II recall involving aripiprazole tablets, USP, 10 mg in 30-count bottles.
The US Food and Drug...
09/24/2025
Pharmacy Learning Network
News
FDA Issues Class I Recall of Cyclobenzaprine Tablets Due to Label Mix-Up with Meloxicam
09/24/2025
Juliet Gallagher
Unichem Pharmaceuticals USA Inc. has initiated a Class I recall of Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, packaged in 90-count bottles.
Unichem Pharmaceuticals USA Inc. has initiated a Class I recall of Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, packaged in 90-count bottles.
Unichem Pharmaceuticals USA Inc....
09/24/2025
Pharmacy Learning Network
News
FDA Issues Class II Recall of Zydus Succinylcholine Chloride Injection Over Impurity Concerns
09/16/2025
Grace Taylor, MS, MA
Zydus Pharmaceuticals has voluntarily recalled multiple lots of Succinylcholine Chloride Injection after FDA testing revealed out-of-specification degradation impurities.
Zydus Pharmaceuticals has voluntarily recalled multiple lots of Succinylcholine Chloride Injection after FDA testing revealed out-of-specification degradation impurities.
Zydus Pharmaceuticals has...
09/16/2025
Pharmacy Learning Network
News
Duloxetine Capsules Recalled Over Nitrosamine Impurity
09/16/2025
Grace Taylor, MS, MA
Breckenridge Pharmaceutical has voluntarily recalled Duloxetine 30 mg capsules after detecting a nitrosamine impurity above interim safety limits, affecting distribution in three US states.
Breckenridge Pharmaceutical has voluntarily recalled Duloxetine 30 mg capsules after detecting a nitrosamine impurity above interim safety limits, affecting distribution in three US states.
Breckenridge Pharmaceutical has...
09/16/2025
Pharmacy Learning Network
News
Sodium Bicarbonate Injection Recalled Over Arsenic Impurity Concerns
09/16/2025
Grace Taylor, MS, MA
Exela Pharma Sciences has issued a Class II recall of its 4.2% Sodium Bicarbonate Injection after testing revealed out-of-specification arsenic levels.
Exela Pharma Sciences has issued a Class II recall of its 4.2% Sodium Bicarbonate Injection after testing revealed out-of-specification arsenic levels.
Exela Pharma Sciences has issued...
09/16/2025
Pharmacy Learning Network
News
KIMMTRAK (tebentafusp-tebn) Injection Recalled Due to Subpotency
09/10/2025
Hannah Musick
A Class II recall has been issued for KIMMTRAK (tebentafusp-tebn) Injection due to subpotency, potentially reducing therapeutic effectiveness in patients with metastatic uveal melanoma.
A Class II recall has been issued for KIMMTRAK (tebentafusp-tebn) Injection due to subpotency, potentially reducing therapeutic effectiveness in patients with metastatic uveal melanoma.
A Class II recall has been...
09/10/2025
Pharmacy Learning Network
News
Class II Recall for Multiple Strengths of Chlorpromazine Tablets Due to Contaminated Packaging Material
09/10/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Chlorpromazine Hydrochloride Tablets due to the presence of a microorganism on polyester coil packaging, posing a potential contamination risk...
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Chlorpromazine Hydrochloride Tablets due to the presence of a microorganism on polyester coil packaging, posing a potential contamination risk...
The US Food and Drug...
09/10/2025
Pharmacy Learning Network
News
FDA Issues Class I Recall for Multiple DermaRite Antiseptic and Analgesic Products Due to Dangerous Microbial Contamination
09/10/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class I recall for multiple DermaRite antiseptic and topical products due to contamination with Burkholderia cepacia, a dangerous bacteria that poses serious infection risks to vulnerable...
The US Food and Drug Administration (FDA) has issued a Class I recall for multiple DermaRite antiseptic and topical products due to contamination with Burkholderia cepacia, a dangerous bacteria that poses serious infection risks to vulnerable...
The US Food and Drug...
09/10/2025
Pharmacy Learning Network

Insights

Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Fighting Endocarditis One Antibiotic at a Time
09/22/2022
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings reviews guideline recommendations and new research into the use of antibiotics in patients who are about to undergo invasive dental procedures.
Dr Jennings reviews guideline recommendations and new research into the use of antibiotics in patients who are about to undergo invasive dental procedures.
Dr Jennings reviews guideline...
09/22/2022
Pharmacy Learning Network

Interactive Features

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
David T. Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Paul Schulz, MD
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
Ronald Vender, MD, FRCPC
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
Abigail Cline, MD, PhD
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; Ryan Nix, BS, NRP, NCI
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
Videos
Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
05/13/2020
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of...
05/13/2020
Pharmacy Learning Network
Videos
Diabetes - Guideline Changes, Adherence, and Newer Drug Issues
09/15/2015
09/15/2015
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use